Viatris Reports Strong Q2 with Growth Prospects
Viatris Inc. reports $3.8B in Q2 revenue, boosts 2024 outlook with innovative pipeline progress and strategic investments.
- Latest
- Trending
Viatris Inc. reports $3.8B in Q2 revenue, boosts 2024 outlook with innovative pipeline progress and strategic investments.
Adicet Bio receives an upgrade from Jones Trading, raising its rating to Buy with a new price target of $6.00. ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.